Hims & Hers revenue rises 4% to $608M, gross margins compress to 65%
Hims & Hers (NYSE:HIMS) posted first-quarter revenue of $608.1 million, a 4% increase compared to $586 million in the prior-year period.
United StatesBreaking News
Energy
Plug Power revenue reaches $163.5M as management eyes year-end EBITDA breakeven
Plug Power (NASDAQ:PLUG) delivered first-quarter 2026 revenue of $163.5 million, a 22% increase over the $133.7 million reported in the same period last year.
ArriVent reports $326M in liquidity, topline Phase 3 FURVENT results expected mid-2026
ArriVent BioPharma (NASDAQ:AVBP) ended the first quarter on March 31, 2026, with $326.4 million in cash, cash equivalents, and short-term investments.
Energy
Mammoth reports $22M in revenue as aviation assets drive segment growth
Mammoth Energy Services (NASDAQ:TUSK) posted total revenue from continuing operations of $22 million for the quarter ended March 31, 2026, up from $11.6 million in the prior-year period.
Technology
American Battery revenue rallies 64%, Nevada plant reaches profitability threshold
American Battery Technology Company (NASDAQ:ABAT) reported revenue of $7.8 million for the quarter ended March 31, 2026, a 64% sequential increase over the prior quarter.
Technology
MIND CTI revenue holds at $5.1M, major customer set to exit in 2027
MIND CTI (NASDAQ:MNDO) posted first-quarter 2026 revenue of $5.1 million, a slight increase from the $5 million reported in the prior-year period.
Apollo to take Emerald private in $1.5 billion deal
Apollo-managed funds have reached a definitive agreement to acquire Emerald (NYSE:EEX) for $5.03 per share in cash, representing a 42.1% premium to the company's unaffected share price.
Liquidia net sales hit $130M as over 3,750 patients begin YUTREPIA therapy
Liquidia (NASDAQ:LQDA) posted net product sales of $129.9 million for the quarter ended March 31, 2026, a result driven entirely by the commercial success of YUTREPIA.
FS KKR reports $1.57 per share net loss, KKR to support buybacks and fee waivers
FS KKR Capital (NYSE:FSK) reported net investment income of $0.42 per share for the first quarter of 2026, meeting internal expectations for core earnings.
Apogee Therapeutics extends cash runway to 2029 as atopic dermatitis data deepens
Apogee Therapeutics (NASDAQ:APGE) ended the first quarter of 2026 with $1.3 billion in cash, cash equivalents, and marketable securities.
Technology
Airship AI revenue rises 15%, positive operating cash flow reaches $0.8M
Airship AI (NASDAQ:AISP) posted net revenue of $6.3 million for the first quarter ended March 31, 2026, representing a 15% increase over the $5.5 million reported in the same period last year.
Braves baseball revenue climbs 60%, mixed-use income hits $26M
Atlanta Braves Holdings (NASDAQ:BATRA) posted total revenue of $72 million for the first quarter ended March 31, 2026, a 53% increase compared to the same period last year.